Project Grant R01HL183249
- Federal Project Grant Award Summary Seattle Children's Hospital, doing business as Seattle Children's Research Institute, received a $160,380 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through August 31, 2029. The award supports the design, refinement, and pilot testing of a community-based intervention to reduce wildfire smoke exposure in children with asthma. The primary...
- Federal Project Grant Award Summary Seattle Children's Research Institute received a $154,980 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through August 31, 2030. This research initiative investigates circadian regulation of epithelial immune responses in asthma, addressing the gap in understanding why asthma symptoms and exacerbations occur more frequently at night. The...
- Federal Project Grant Award Summary Boston Children's Hospital received a $809,162 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 15, 2025, with a completion date of June 30, 2030. This award supports research investigating pulmonary ionocyte function and development using induced pluripotent stem cell (iPSC)-derived airway epithelium models. The research aims to advance...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $182,234 to The Children's Hospital of Philadelphia (CHOP) under the Cardiovascular Diseases Research program (CFDA 93.837) on July 16, 2025, for a project titled "Air Pollution Sensitivity in Pediatric Asthma." The award period extends through April 30, 2027. Led by Dr. Jelte Kelchtermans, an instructor at the University of Pennsylvania and attending physician in pulmonary and sleep...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $189,000 to the University of Colorado-Denver on September 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a proof-of-principle research study investigating environmental factors affecting treatment responsiveness in pediatric acute asthma exacerbations. The project, which extends through August 31, 2027, will deliver scientific research and preliminary data...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $176,220 Project Grant to the University of Wisconsin–Madison on August 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to support a career development research initiative investigating gene-by-air pollution interactions in preschool-onset childhood asthma. The award, which extends through May 31, 2030, funds a comprehensive research program designed to identify genetic and...
- Federal Grant Award Summary Cincinnati Children's Hospital Medical Center received a $727,575 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 15, 2025, with completion targeted for May 31, 2030. The project will investigate the cellular mechanisms and clinical impact of the genetic variant rs7512462 within the SLC26A9 gene on individual patient responses to cystic fibrosis (CF)...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Connecticut Health Center a $293,395 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) effective August 15, 2025, with a completion date of July 31, 2028. This award supports the "Democratizing Access to Cleaner Residential Air" (DACRA) initiative, which investigates the efficacy and feasibility of low-cost Corsi-Rosenthal boxes as an intervention to reduce...
- Federal Project Grant Award Summary The University of California, San Francisco received a $190,998 Project Grant from the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837), awarded August 1, 2025, with completion targeted for July 31, 2030. This research initiative, titled "Understanding Pulmonary Fibrosis Through the Integration of Complex Occupational and Environmental Exposure Assessments," delivers epidemiologic research...
- Federal Grant Award Summary Cincinnati Children's Hospital Medical Center received a $441,375 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded August 15, 2025, with completion targeted for July 31, 2027. The award funds research to develop and optimize a dual adeno-associated virus (AAV) gene delivery system employing intein technology to deliver full-length, functional cystic fibrosis transmembrane...
Seattle Children's Research Institute received a $893,522 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded May 1, 2026, with completion targeted for April 30, 2031. The award funds the HOME AIR POLLUTION IN CHILDREN WITH CYSTIC FIBROSIS (HEROIC-CF) project, which investigates the relationship between ambient air pollution exposure and lung disease severity in children with cystic fibrosis (CF), with particular focus on health disparities affecting Hispanic children with CF. The research deliverables include epidemiological analysis utilizing two major datasets—the Cystic Fibrosis Foundation Patient Registry and the University of Washington Spatiotemporal Air Pollution Exposure Model—to determine whether neighborhood-level air pollution exposure differs between Hispanic and non-Hispanic white children with CF and how such exposure correlates with pulmonary disease progression. The multidisciplinary research team will examine non-genetic environmental factors that account for approximately 50 percent of lung disease severity variability in CF populations. Research outputs are expected to generate critical evidence regarding environmental drivers of health disparities in Hispanic children with CF and inform understanding of air pollution's influence on lung disease severity across the broader pediatric CF population.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $893.5k | 5/5/26 |